AQP5 and endometrium adenocarcinoma: As 2 reports demonstrated decreased migration of human epithelial ovarian cancer (53) or endometrial adenocarcinoma cells (54) after downregulation of AQP-5, we set out to quantify cell migration of ATII cells differentiated to ATI cells.